This move is archived. Current quotes and coverage live on the stock page.
Get TELO alerts:
Telo Genomics Corp's stock has taken a significant hit, dropping 12.50% in today's trading session.
Investors in Telo Genomics Corp (TELO.V) are feeling the pinch today as the stock plummets to CA$0.04, marking a notable decline of 12.50%. With a market cap of just over CA$4 million, this drop raises concerns about the company's stability and future prospects.
Advertisement
Telo Genomics Corp
TELO.V
TELO.V
Telo Genomics Corp
WealthAwesomeMarket cap
$5.02M
52W high
$0.10
52W low
$0.04
1W change
+11.11%
Beta
0.18
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELO's historical volatility
30-Day Vol
134.9%
Annualized
90-Day Vol
124.9%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The sharp decline in Telo Genomics' stock price highlights the volatility often associated with small-cap biotech firms, particularly in the absence of significant news or developments.
Telo Genomics Corp down 12.50% in one trading day.
With a market cap of CA$4,017,219, Telo Genomics remains a small player in the biotech sector, making it susceptible to significant price swings.
Bull case
Despite today's downturn, Telo Genomics is making progress in expanding its operations and forming partnerships, which could set the stage for future growth.
Bear case
The lack of recent news or positive developments raises concerns that there may be underlying issues affecting investor confidence in Telo Genomics.
Market Reaction
Advertisement
Today's 12.50% decline in Telo Genomics' stock is a stark reminder of the volatility that can plague small-cap biotech companies. Investors are left questioning the company's future as it faces challenges in gaining traction in a competitive industry.
Company Background
Telo Genomics Corp focuses on innovative diagnostic technologies, but with a market cap of just over CA$4 million, its financial health is under scrutiny. The company has recently relocated its laboratories to a larger facility in Toronto, which could be a positive sign for future growth, but investor sentiment remains cautious.
Looking Ahead
As Telo Genomics navigates its current challenges, investors should keep an eye on upcoming announcements and developments that could influence stock performance. The biotech sector is known for rapid changes, and any positive news could quickly shift the narrative.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
